99mTc Certolizumab

N/A

Report date: 2025/09/08 16:21:23

NME

Base Information

Drug Name99mTc Certolizumab

Drug Alias NameTechnetium[99mTc]-CertolizumabTechnetium-labeled certolizumab pegol

ClassificationRadiation-emitting products > Nuclides > Technetium > 99mTcRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug Conjugates

Mechanisms of ActionTumor necrosis factor α modulators

TargetsTumor necrosis factor α

Therapy Area/IndicationsAxial Spondyloarthritis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryBelgium

CombinationsNo

Global Highest StatusPhase 3 Clinical

Highest Status in ChinaN/A

Originator CompaniesUniversitair Ziekenhuis Gent

China Registration ClassN/A

Develop Information

Active CompaniesUniversitair Ziekenhuis Gent

Inactive CompaniesN/A

Active IndicationsAxial Spondyloarthritis

Inactive IndicationsN/A

Other Information

ATC CodeN/A